Hadly Clark is an associate director on the FasterCures team at Milken Institute Health. She is an experienced health care professional focused on the intersection of health and technology and leads oncology-focused initiatives exploring innovative screening technologies and anti-cancer treatments.
Technological innovation in the health landscape is occurring rapidly, and much of it would not be possible without patient data. Health data sets can be leveraged to build new tools that can help diagnose disease, remotely monitor and track patients, and make groundbreaking discoveries that lead to new treatments and cures. Technology companies, which have already disrupted countless industries, have the most advanced capabilities to organize data, create consumer products based on data-driven insights, and make information universally accessible in ways that are certainly applicable to the health space.
However, because they have not traditionally played a central role in the healthcare landscape, their participation carries substantial implications for how patient data are collected and used. This environment of uncertainty impacts patients’ levels of trust and, as a result, their levels of engagement in biomedical research.
This report summarizes our interview series on data-driven patient participation in research, and our private roundtable focused on building trust to achieve a shared vision for patient data. It describes key themes that have emerged from these efforts and briefly mentions upcoming work that will build on this foundation.
Multimillion-dollar program dedicates funds to advance sarcoidosis knowledge Full Proposals due January 10, 2022 WASHINGTON, DC, October 4, 2021 —The Milken Institute’s Center for Strategic Philanthropy and Ann Theodore Foundation today...
Poor treatment options. No Cure. Patients and families affected by chronic myelomonocytic leukemia (CMML) face many challenges and critical unmet needs, issues mirrored by the current state of the disease’s research. On a societal scale...
September 17, 2024 (Washington, DC) —The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation, today announced that more than $2.4 million in funding is...
Paul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence.
The fuel for biomedical innovation is data. Data-driven patient participation — or patient contribution of their biospecimens, self-reported or wearable data, health record data, and other information — has emerged as a tool that may help...
The Misophonia Research Fund (MRF) and the Milken Institute have partnered for the past four years to advance a world where misophonia is scientifically understood and effective treatments are available to help anyone who lives with this...
The Milken Institute Center for Strategic Philanthropy, in partnership with the Ann Theodore Foundation (ATF), is pleased to announce a new Request for Proposals (RFP) focused on understanding the underlying biology of sarcoidosis, an...
Chad Clinton is the director of media relations for the Milken Institute. Hired to this role in August 2021, Clinton develops and executes strategies to amplify the Institute’s core messages by generating coverage of its pillar workstreams, experts, and events.
The Milken Institute Center for Strategic Philanthropy and the Ann Theodore Foundation have released a new request for proposals (RFP) focused on understanding the underlying biology of sarcoidosis. Applications are open through January 20...
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutting-edge biomedical innovations to patients. The center was instrumental in gaining support for the 21st Century Cures Act in 2016, and...
Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the brain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe. The prognosis for...
September 25, 2024 (Washington, DC)—The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), today announced...
Paul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence.
At FasterCures, we have spent nearly 20 years working toward building a system that is effective, efficient, and driven by a clear vision: patient needs above all else. We believe that transformative and life-saving science should be fully...
Shepherding a drug from discovery to the market is a complex process that involves many actors. The process often begins with academic researchers making a breakthrough discovery in the lab and ends with pharmaceutical companies running...